Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marinos Dalakas, MD
Coordinating Investigator
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Montreal Neurological Institute Clinical Research Unit, Mcgill University
Montreal, Quebec, Canada
- Thomayerova Nemocnice, Klinicko-Farmakologická Jednotka
Prague, Czechia
- Aarhus Universitets Hospital-Neurologisk Forskning
Aarhus N, Denmark
- Rigshospitalet
København Ø, Denmark
- Charité Campus Mitte
Berlin, Germany
- Hannover Medical School
Hanover, Germany
- Universitätsklinikum Jena
Jena, Germany
- Klinik Für Konservative Orthopädie Und Des Poliozentrums
Koblenz, Germany
- Westfälische Wilhelms-Universität Münster
Münster, Germany
- Azienda Ospedaliera Universitaria Integrata Verona (ospedale Borgo Roma)
Verona, Italy
- Academisch Medisch Centrum Amsterdam Umc, Locatie Amc
Amsterdam, Netherlands
- Medtrials
Krakow, Poland
- Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie
Lublin, Poland
- Clinical Research Center Sp. Z O.O.
Poznan, Poland
- Samodzielny Publiczny Centralny Szpital Kliniczny
Warsaw, Poland
- Institut Guttman
Badalona, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Washington University
St Louis, Missouri, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Sept 2014
- Primary completion
- 24 Nov 2022
- Completion
- 24 Nov 2022
- Last update posted
- 5 Dec 2025
- Registered enrollment
- 191
- Registry id
- NCT02176863
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.